Stock 002873 GUIYANG XINTIAN PHARMACEUTICAL CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Guiyang Xintian Pharmaceutical Co.,Ltd.

Equities

002873

CNE100002QB5

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-05-30 pm EDT 		5-day change 1st Jan Change
9.75 CNY +0.93% Intraday chart for Guiyang Xintian Pharmaceutical Co.,Ltd. -4.04% -21.75%
May. 03 Guiyang Xintian Pharmaceutical Co.,Ltd.'s Equity Buyback announced on February 6, 2024, has expired with 8,806,030 shares, representing 3.81% for CNY 75.3 million. CI
Apr. 27 Guiyang Xintian Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Guiyang Xintian Pharmaceutical Co.,Ltd. Approves Cash Dividend for 2023
Guiyang Xintian Pharmaceutical Co.,Ltd.'s Equity Buyback announced on February 6, 2024, has expired with 8,806,030 shares, representing 3.81% for CNY 75.3 million.
Guiyang Xintian Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Guiyang Xintian Pharmaceutical Co.,Ltd. Announces Profit Distribution Proposal for 2023
Guiyang Xintian Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Guiyang Xintian Pharmaceutical Co.,Ltd. signed Transaction Framework Agreement to acquire remaining 85.12% stake in Shanghai Huilun Biotechnology Co., Ltd.
Tranche Update on Guiyang Xintian Pharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on February 6, 2024.
Guiyang Xintian Pharmaceutical Co.,Ltd. announces an Increase in Equity Buyback.
Guiyang Xintian Pharmaceutical Co.,Ltd. announces an Equity Buyback for CNY 50 million worth of its shares.
Guiyang Xintian Pharmaceutical Co.,Ltd. authorizes a Buyback Plan.
Tranche Update on Guiyang Xintian Pharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on December 23, 2023.
Guiyang Xintian Pharmaceutical Co.,Ltd.'s Equity Buyback announced on December 23, 2023 has closed with 4,017,200 shares, representing 1.73% for CNY 38.41 million.
Guiyang Xintian Pharmaceutical Co.,Ltd. announces an Increase in Equity Buyback.
Tranche Update on Guiyang Xintian Pharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on December 23, 2023.
Guiyang Xintian Pharmaceutical Co.,Ltd. announces an Equity Buyback for CNY 15 million worth of its shares.
Guiyang Xintian Pharmaceutical Co.,Ltd. authorizes a Buyback Plan.
Guiyang Xintian Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Guiyang Xintian Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Guiyang Xintian Pharmaceutical Co.,Ltd. Announces Cash Dividend on A Shares for the Year 2022, Payable on 01 June 2023
Guiyang Xintian Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 002873 Stock
  4. News Guiyang Xintian Pharmaceutical Co.,Ltd.
  5. Other languages